Dendrimer-drug Nanoparticle Synthesis
Award Notice Posted
- Solicitation number
- W81XWH-15-R-0061
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Awarded
- to The Johns Hopkins University
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- W81XWH-16-C-0053 Federal contract award
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- PSC
- Not on record
- Place of performance
- The Johns Hopkins University 3400 N Charles Street W400 Wyman Park Bldg Baltimore, Maryland 21218, United States
Notice details come from SAM.gov. Updated .
Notice text
The United States Army Medical Research Acquisition Activity (USAMRAA) issued a Sole Source Firm Fixed Price-Level of Effort contract to The Johns Hopkins University, Baltimore, MD to continue evaluation of neuroprotective agents that make it possible to assess injury severity and to predict outcomes as well as macrophage cell tracking and structural imaging through outcome measurement of Magnetic Resonance Imaging (MRI) in mild traumatic brain injury (mTBI) in accordance with Walter Reed Army Institute of Research (WRAIR) animal model using Johns Hopkins University School of Medicine Dendrimer-drug Nanoparticle Therapy (US patent #8,889,101, Awarded 2014).
Files
| File | Type | Posted |
|---|---|---|
| Redacted_JA15259.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| Dendrimer-Drug Nanoparticles Synthesis | Award Notice |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity